In addition, the tumorigenicity of cancer stem cells was found to be promoted by EZH2 via the binding and methylation of STAT3 in glioblastoma and in a model of prostate cancer (Xu et al., 2012; Kim et al., 2013). This evidence concerns the gene STAT3 and prostate carcinoma.